- Home
- CV vs DHF Comparison
CV vs DHF Comparison
Compare CV & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CV
- DHF
- Stock Information
- Founded
- CV 2005
- DHF 1998
- Country
- CV United States
- DHF United States
- Employees
- CV N/A
- DHF N/A
- Industry
- CV
- DHF Finance Companies
- Sector
- CV
- DHF Finance
- Exchange
- CV NYSE
- DHF Nasdaq
- Market Cap
- CV 194.2M
- DHF 172.4M
- IPO Year
- CV 2025
- DHF N/A
- Fundamental
- Price
- CV $4.54
- DHF $2.60
- Analyst Decision
- CV
- DHF
- Analyst Count
- CV 0
- DHF 0
- Target Price
- CV N/A
- DHF N/A
- AVG Volume (30 Days)
- CV 1.0M
- DHF 451.1K
- Earning Date
- CV 01-01-0001
- DHF 01-01-0001
- Dividend Yield
- CV N/A
- DHF 7.65%
- EPS Growth
- CV N/A
- DHF N/A
- EPS
- CV N/A
- DHF N/A
- Revenue
- CV $12,044,000.00
- DHF N/A
- Revenue This Year
- CV N/A
- DHF N/A
- Revenue Next Year
- CV N/A
- DHF N/A
- P/E Ratio
- CV N/A
- DHF N/A
- Revenue Growth
- CV 20.54
- DHF N/A
- 52 Week Low
- CV $3.49
- DHF $2.06
- 52 Week High
- CV $5.72
- DHF $2.39
- Technical
- Relative Strength Index (RSI)
- CV N/A
- DHF 57.53
- Support Level
- CV N/A
- DHF $2.57
- Resistance Level
- CV N/A
- DHF $2.61
- Average True Range (ATR)
- CV 0.00
- DHF 0.03
- MACD
- CV 0.00
- DHF -0.00
- Stochastic Oscillator
- CV 0.00
- DHF 61.80
About CV CAPSOVISION INC
CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company's core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. It invests predominantly in fixed-income securities of below-investment-grade credit quality.